Testing effectiveness (Phase 2)Looking for participantsNCT07284628What this trial is testingVortioxetine for Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma University of Zurich 78
Not applicableStudy completedNCT01702610What this trial is testingPhase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forGlioblastoma Mutliforme McGill University Health Centre/Research Institute of the McGill University Health Centre 50
Testing effectiveness (Phase 2)Study completedNCT00525525What this trial is testingStudy of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or GliosarcomaWho this might be right forGlioblastomaGliosarcoma University of California, San Francisco 74
Early research (Phase 1)Study completedNCT02337426What this trial is testingDimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forAdult Brain GlioblastomaAdult Giant Cell GlioblastomaAdult Gliosarcoma Virginia Commonwealth University 12
Not applicableWithdrawnNCT01169415What this trial is testingEffects of Steroid Tapering on Functional Capacity and NeurocognitionWho this might be right forGlioblastoma Multiforme Duke University
Early research (Phase 1)Ended earlyNCT00623077What this trial is testingMT2004-30: Tomotherapy for Solid TumorsWho this might be right forBrain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more Masonic Cancer Center, University of Minnesota 23
Early research (Phase 1)Study completedNCT01119599What this trial is testingRO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaWho this might be right forAcoustic SchwannomaAdult Anaplastic (Malignant) MeningiomaAdult Anaplastic Astrocytoma+26 more National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT01013285What this trial is testingBevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaWho this might be right forBrain and Central Nervous System Tumors Jonsson Comprehensive Cancer Center 70
Large-scale testing (Phase 3)Study completedNCT00916409What this trial is testingEffect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)Who this might be right forGlioblastoma Multiforme NovoCure Ltd. 700
Testing effectiveness (Phase 2)Active Not RecruitingNCT03405792What this trial is testingStudy Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)Who this might be right forGlioblastomaGlioblastoma, WHO Grade IV University of Florida 40
Early research (Phase 1)Study completedNCT03452930What this trial is testingTinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated GlioblastomaWho this might be right forGlioblastomaGliosarcomaMGMT-Unmethylated Glioblastoma M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00869401What this trial is testingDasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Alliance for Clinical Trials in Oncology 217
Testing effectiveness (Phase 2)WithdrawnNCT00006263What this trial is testingCarboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade GliomaWho this might be right forBrain and Central Nervous System Tumors NYU Langone Health
Testing effectiveness (Phase 2)Active Not RecruitingNCT03197506What this trial is testingPembrolizumab and Standard Therapy in Treating Patients With GlioblastomaWho this might be right forGlioblastomaGliosarcomaSupratentorial Glioblastoma Mayo Clinic 52
Not applicableEnded earlyNCT00756106What this trial is testingMRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic GliomaWho this might be right forBrain and Central Nervous System Tumors Massachusetts General Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02715609What this trial is testingDisulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma Multiforme Washington University School of Medicine 35
Testing effectiveness (Phase 2)Study completedNCT00022256What this trial is testingMotexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00014170What this trial is testingGefitinib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma National Cancer Institute (NCI) 92
Testing effectiveness (Phase 2)Study completedNCT00004073What this trial is testingSuramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 54
Testing effectiveness (Phase 2)Study completedNCT00004017What this trial is testingRadiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic AstrocytomaWho this might be right forBrain and Central Nervous System Tumors Peregrine Pharmaceuticals 60